CDMO Micro-Sphere, which offers spray drying and capsule filling for DPI formulations, said that it has now added new particle engineering R&D space with FluidAir PolarDry electrostatic spray drying technology. The company recently announced the addition of new inhalation testing laboratory space at its site in Monteggio, Switzerland. The PolarDry system works at significantly lower temperatures than conventional spray drying technology, making it possible to spray dry heat sensitive formulations.
Micro-Sphere Managing Director Michael Grassberger commented, “We continue to invest in our state-of-the-art facility to support the demand for high-quality formulation development and manufacturing. Our new R&D service is in response to market demand and highlights our continued intent to work with our clients to improve drug development and delivery. The R&D department strengthens our ability to offer proof-of-concept and feasibility studies in fast, flexible and economic ways for steering and anticipating strategic decisions and influencing up-scaling processes in clinical and commercial phases.”
Grassberger added, “The introduction of electrostatic spray drying is unique for the Pharma industry and we are very proud to partner with FluidAir to be the first CDMO to introduce this service which offers the customer increased efficiencies and a scalable process from lab scale up to pilot scale which allows us to quickly move from R&D to clinical stage in-house. Combine this new service with our innovative analytical capabilities, conventional spray drying in lab scale, micronization and integrated solutions including QbD, and we are excellently placed to offer the experience and expertise our customers need for the efficient delivery of clinical and commercial products.”
